Clinical Study on Adoptive Treatment of MDR-TB With Allogeneic γδT Cells

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2018
All patients with multi‐drug resistant pulmonary tuberculosis will be assigned into 2 groups(study group and control group),both groups will receive conventional treatment. Allogeneic γδT cell will be administrated intravenously to patients in the study group (but not the control group) every two weeks for 6 months
Epistemonikos ID: 29be16d4a69c440c0c1bc4b60bca9cbb0deae544
First added on: May 21, 2024